Literature DB >> 2159256

Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria.

R C Goldman1, S W Fesik, C C Doran.   

Abstract

Erythromycin binds to a single site on the bacterial 50S ribosomal subunit and perturbs protein synthesis. However, erythromycin contains desosamine and thus exists in both protonated (greater than 96%) and neutral (less than 4%) forms at physiological pH because of the pKa of the dimethylamino group. We therefore examined the relative roles of both forms in binding to ribosomes isolated from two species each of gram-positive and gram-negative bacteria. We developed a system to directly measure the forward (association) rate constant of formation of the macrolide-ribosome complex, and we have measured both the forward and reverse (dissociation) rate constants as a function of pH. Forward rate constants and binding affinity did not correlate with pH when the interaction of erythromycin with ribosomes from both gram-positive and gram-negative bacteria was examined, demonstrating that the protonated form of this macrolide binds to ribosomes. Conversely, the neutral form of macrolide cannot be the sole binding species and appears to bind with the same kinetics as the protonated form. Forward rate constants were 3- to 4-fold greater at physiological pH, and binding affinity calculated from rate constants was 5- to 10-fold greater than previously estimated. Similar results were obtained with azithromycin, a novel 15-membered macrolide that contains an additional tertiary amine in the macrolide ring. Ribosome- and macrolide-specific kinetic parameters were demonstrated at neutral pH and may be related to the potency of the two macrolides against gram-positive and gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159256      PMCID: PMC171609          DOI: 10.1128/AAC.34.3.426

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Interaction between the erythromycin and chloramphenicol binding sites on the Escherichica coli ribosome.

Authors:  R Langlois; C R Cantor; R Vince; S Pestka
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

2.  Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol.

Authors:  S B Taubman; N R Jones; F E Young; J W Corcoran
Journal:  Biochim Biophys Acta       Date:  1966-08-17

3.  Two types of binding of erythromycin to ribosomes from antibiotic-sensitive and -resistant Bacillus subtilis 168.

Authors:  N L Oleinick; J W Corcoran
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

4.  Mode of action of macrolides.

Authors:  J C Mao; R G Wiegand
Journal:  Biochim Biophys Acta       Date:  1968-04-22

5.  The intermolecular complex of erythromycin and ribosome.

Authors:  J C Mao; M Putterman
Journal:  J Mol Biol       Date:  1969-09-14       Impact factor: 5.469

6.  Determination of rate constants for in vitro three-compartment transfer using a two-phase system.

Authors:  M H Yunker; S Borodkin
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

7.  Studies on the antibiotics from Streptomyces spinichromogenes var. kujimyceticus. V. Some antimicrobial characteristics of kujimycin A and kujimycin B against macrolide resistant staphylococci.

Authors:  S Omura; S Namiki; M Shibata; T Muro; J Sawada
Journal:  J Antibiot (Tokyo)       Date:  1970-09       Impact factor: 2.649

8.  The distance between two functionally significant regions of the 50 S Escherichia coli ribosome: the erythromycin binding site and proteins L7/L12.

Authors:  R Langlois; C C Lee; C R Cantor; R Vince; S Pestka
Journal:  J Mol Biol       Date:  1976-09-15       Impact factor: 5.469

9.  Binding of [14C]erythromycin to Escherichia coli ribosomes.

Authors:  S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

10.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09
View more
  11 in total

1.  Fluorescence polarization method to characterize macrolide-ribosome interactions.

Authors:  Kang Yan; Eric Hunt; John Berge; Earl May; Robert A Copeland; Richard R Gontarek
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae.

Authors:  David H Sherman; Shengying Li; Liudmila V Yermalitskaya; Youngchang Kim; Jarrod A Smith; Michael R Waterman; Larissa M Podust
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

3.  Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.

Authors:  J O Capobianco; Z Cao; V D Shortridge; Z Ma; R K Flamm; P Zhong
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 4.  Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians.

Authors:  Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid
Journal:  Open Forum Infect Dis       Date:  2022-06-15       Impact factor: 4.423

5.  Structural insight into the antibiotic action of telithromycin against resistant mutants.

Authors:  Rita Berisio; Joerg Harms; Frank Schluenzen; Raz Zarivach; Harly A S Hansen; Paola Fucini; Ada Yonath
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

6.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.

Authors:  Jürg Dreier; Eva Amantea; Laurenz Kellenberger; Malcolm G P Page
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

Review 8.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 9.  Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  S M Holliday; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.

Authors:  R C Goldman; J O Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.